Lots of speculations running rampant.
This is what we know.
1. NWBO has a long term lease agreement for the facility in Sawston.
2. NWBO has built 2 production suites in that facility.
3. NWBO has an agreement with Advent to produce DCVax-L, currently under the specials program in a facility in London.
4. Once the facility in Sawston gets it's GMP certification, the production for the specials program will move to the facility in Sawston.
5. Advent will be the contract manufacturer of the specials program DCVax-L that will be produced in the facility in Sawston.
6. NWBO is dependent upon the facility in Sawston to be able to show MHRA that they are capable of producing DCVax-L on a larger scale prior to getting DCVax-L approved.
7. Approval is the absolute most important future event if NWBO is to be successful (Obviously a good/great phase III result is a must before they can get approved).
8 NWBO is paying for the added workforce that Advent is currently assembling in order to show that once approved, NWBO will be able to produce DCVax-L on a larger scale. This workforce will be put to work to produce DCVax-L once the facility in Sawston gets certified. First under the specials program, in the future under the MHRA approval.
What we know for sure is that Advent is currently not using the sawston facility to produce anything as it is not certified. If they are currently servicing other customers it is at another facility, possible London. We have no information in regard to Advent using the Sawston facility in the future for other customers. We do not know the arrangements between NWBO and Advent for such future use. We will know more about those arrangements if they were to happen, through future financial statements. It is PURE SPECULATION to say that NWBO will let Advent use the facility in Sawston for other customers for free.
If anyone has other known facts about the facility in Sawston, please contribute. I don't mean wild speculations and accusations not based in what we know.
AI
Market Data 
Markets 
